PHILADELPHIA -- The first colonoscopy done on a person has the
greatest impact for preventing death from colorectal cancer, and
subsequent surveillance colonoscopies play a lesser role, based on a new
analysis of 20-year follow-up data collected in the National Polyp
Study.
"Initial colonoscopy has a marked and significant impact on
reducing colon cancer long term," Ann G. Zauber, Ph.D., said at the
annual meeting of the American College of Gastroenterology.
"The current guidelines of colonoscopy surveillance every 3
years for the higher-risk adenoma patients, and less frequent
surveillance, every 5-10 years, for the lower-risk adenoma patients, are
supported by these findings," Dr. Zauber said in an interview.
"The implication is to use high-quality colonoscopies, and
stratify subsequent surveillance to low-risk and high-risk adenoma
patients," which is what current guidelines recommend. "This
strategy should reduce colorectal cancer mortality and efficiently use
colonoscopic resources," said Dr. Zauber, a biostatistician at
Memorial Sloan Kettering Cancer Center in New York.
As the analysis by Dr. Zauber and her associates is extended
further, it may show that the interval between follow-up surveillance
colonoscopies could be lengthened even more for low-risk patients. So
far, there is limited evidence on surveillance intervals longer than
5-10 years, she said.
"A goal is to identify low-risk patients in the cohort"
who may be able to have less frequent surveillance, commented Dr.
Douglas K. Rex, professor of medicine and director of endoscopy at
Indiana University in Indianapolis. The type of analysis done by Dr.
Zauber may provide useful information that leads to changes in
surveillance recommendations, Dr. Rex said in an interview.
Dr. Zauber performed a microsimulation screening analysis on data
collected in the National Polyp Study. The study began by screening more
than 9,000 people. Out of this group, about 2,600 people were identified
with adenomatous polyps, and they were followed over the next 20 years.
The National Polyp Study has been led by Dr. Sidney Winawer.
The microsimulation analysis divided the adenoma-carcinoma sequence
into stages based on its natural history and generated three models. One
model predicted the mortality rate from colorectal cancer if no initial
colonoscopy and polypectomy had ever been done, the second model
predicted the impact of initial screening only, and the third model
calculated the impact of both screening colonoscopy and subsequent
surveillance colonoscopies.
If no colonoscopy had ever been done, the predicted 20-year
mortality rate from colorectal cancer in patients with adenomatous
polyps would be about 5.5%. With screening colonoscopy alone, this
mortality rate was cut to about 2.5%. Surveillance colonoscopies lowered
the mortality rate still lower, to about 0.9%.
The implication is that the initial screening colonoscopy had the
biggest impact on mortality. Surveillance colonoscopies also played a
role in further reducing mortality, but the effect was not as great as
that of the first colonoscopy.
In earlier reports, researchers from the National Polyp Study
showed that patients with three or more adenomas at baseline have an
increased risk of subsequent advanced adenomas or colorectal cancer.
Current guidelines call for surveillance colonoscopy at 3 years in these
patients and in patients with adenomas greater than or equal to 1 cm in
size, or with high-grade dysplasia or villous elements. People at lower
risk for subsequent advanced adenomas or colorectal cancer can have
surveillance colonoscopies at longer intervals. Current guidelines call
for follow-up at 5-10 years.
One caveat is that the screening colonoscopies done in the National
Polyp Study "did an extremely good job at clearing polyps at
baseline," Dr. Rex noted. "We may not see the same impact from
screening colonoscopies" in everyday practice, he cautioned, unless
the quality of these colonoscopies is very high.
BY MITCHEL L. ZOLER
Philadelphia Bureau
COPYRIGHT 2007 International Medical News
Group Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
Copyright 2007 Gale, Cengage Learning. All rights
reserved. Gale Group is a Thomson Corporation Company.
NOTE: All illustrations and photos have been removed from this article.